Rhoen Klinikum AG
SWB:RHK

Watchlist Manager
Rhoen Klinikum AG Logo
Rhoen Klinikum AG
SWB:RHK
Watchlist
Price: 12.3 EUR 0.82%
Market Cap: €823.3m

Rhoen Klinikum AG
Investor Relations

Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern and currently employs 18,227 full-time employees. The company operates acute hospitals, medical care centers and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic Clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2021
Call Date
Nov 11, 2021
AI Summary
Q3 2021

Revenue Growth: RHÖN-KLINIKUM reported a 1.2% increase in revenue for the first 9 months of 2021 compared to the prior year.

Profitability: EBITDA rose by 16.9% to EUR 71.1 million, and consolidated profit was EUR 15.5 million, up EUR 13.2 million from last year.

Updated Guidance: The company raised its 2021 EBITDA guidance to between EUR 92 million and EUR 102 million, reflecting improved business performance.

Stable Balance Sheet: The equity ratio was around 73%, one of the highest in the industry, with management emphasizing financial solidity.

Pandemic Impact: COVID-19 continued to affect operations and staff, but experience and vaccination progress provided some confidence for ongoing care.

Key Financials
Revenue
EUR 1,360.2 million
EBITDA
EUR 71.1 million (first 9 months 2021)
Consolidated Profit
EUR 15.5 million (first 9 months 2021)
Equity Ratio
73%
COVID-19 Compensation Income
EUR 40.3 million (first 9 months 2021); EUR 90.6 million (2020)
Earnings Call Recording
Other Earnings Calls
2021
2018

Management

Dr. Tobias Kaltenbach
CEO & Chairman of Management Board
No Bio Available
Mr. Julian Schmitt
Head of Investor Relations & Treasury
No Bio Available
Mr. Eugen Münch
Chief Representative
No Bio Available

Contacts

Address
BAYERN
Bad Neustadt an der Saale
Schlossplatz 1
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett